CASE COMMENTS: CARTELS – EUROPEAN UNION – PHARMACEUTICAL SECTOR – REPORT

Report: The Commission publishes a report on the application of competition law in the pharmaceutical sector and recommends to implement a cooperation between national competition authorities in order to deliver more affordable medicines and promote innovation (Pharmaceutical)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On 28 January 2019, the European Commission published its report on the application of competition law in the pharmaceutical sector, in which it calls for better collaboration between European competition authorities to promote access to affordable and innovative medicines. As luck would have it, this column was finalised on the same day that the Competition Authority, in turn, presented its report on the health sector. The

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Michel Debroux, Report: The Commission publishes a report on the application of competition law in the pharmaceutical sector and recommends to implement a cooperation between national competition authorities in order to deliver more affordable medicines and promote innovation (Pharmaceutical), 28 January 2019, Concurrences N° 2-2019, Art. N° 90131, p. 72

Visites 274

All reviews